These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23434226)

  • 21. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
    J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.
    Huang W; Liu Y; Wang J; Yuan X; Jin HW; Zhang LR; Zhang JT; Liu ZM; Cui JR
    Eur J Med Chem; 2018 Sep; 157():887-897. PubMed ID: 30145375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy.
    Masciocchi D; Gelain A; Villa S; Meneghetti F; Barlocco D
    Future Med Chem; 2011 Apr; 3(5):567-97. PubMed ID: 21526897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The IκB Kinase Inhibitor ACHP Targets the STAT3 Signaling Pathway in Human Non-Small Cell Lung Carcinoma Cells.
    Lee JH; Mohan CD; Basappa S; Rangappa S; Chinnathambi A; Alahmadi TA; Alharbi SA; Kumar AP; Sethi G; Ahn KS; Rangappa KS
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31847229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3).
    Chen H; Yang Z; Ding C; Xiong A; Wild C; Wang L; Ye N; Cai G; Flores RM; Ding Y; Shen Q; Zhou J
    Eur J Med Chem; 2014 Jul; 82():195-203. PubMed ID: 24904966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
    Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
    Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation.
    Dong J; Cheng XD; Zhang WD; Qin JJ
    J Med Chem; 2021 Jul; 64(13):8884-8915. PubMed ID: 34170703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel small molecules that inhibit STAT3-dependent transcription and function.
    Kolosenko I; Yu Y; Busker S; Dyczynski M; Liu J; Haraldsson M; Palm Apergi C; Helleday T; Tamm KP; Page BDG; Grander D
    PLoS One; 2017; 12(6):e0178844. PubMed ID: 28636670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain.
    Page BD; Fletcher S; Yue P; Li Z; Zhang X; Sharmeen S; Datti A; Wrana JL; Trudel S; Schimmer AD; Turkson J; Gunning PT
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5605-9. PubMed ID: 21788134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.
    Liu Y; Liu A; Xu Z; Yu W; Wang H; Li C; Lin J
    Apoptosis; 2011 May; 16(5):502-10. PubMed ID: 21311975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery, synthesis, and evaluation of small-molecule signal transducer and activator of transcription 3 inhibitors.
    Shi ZB; Zhao D; Huang YY; Du Y; Cao XR; Gong ZN; Zhao R; Li JX
    Chem Pharm Bull (Tokyo); 2012; 60(12):1574-80. PubMed ID: 23207637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and utilization of activated STAT3 detection assays for screening a library of secreted proteins.
    Fursov N; Gates IV; Panavas T; Giles-Komar J; Powers G
    Assay Drug Dev Technol; 2011 Aug; 9(4):420-9. PubMed ID: 21294636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule inhibitors of STAT3 for cancer therapy.
    Zhao M; Jiang B; Gao FH
    Curr Med Chem; 2011; 18(26):4012-8. PubMed ID: 21824090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
    Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
    PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 17-hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells.
    Wang Y; Ma X; Yan S; Shen S; Zhu H; Gu Y; Wang H; Qin G; Yu Q
    Cancer Res; 2009 Sep; 69(18):7302-10. PubMed ID: 19706767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein.
    Debnath B; Xu S; Neamati N
    J Med Chem; 2012 Aug; 55(15):6645-68. PubMed ID: 22650325
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel activators and small-molecule inhibitors of STAT3 in cancer.
    Yang L; Lin S; Xu L; Lin J; Zhao C; Huang X
    Cytokine Growth Factor Rev; 2019 Oct; 49():10-22. PubMed ID: 31677966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel small-molecule inhibitor of IL-6 signalling.
    Zinzalla G; Haque MR; Basu BP; Anderson J; Kaye SL; Haider S; Hasan F; Antonow D; Essex S; Rahman KM; Palmer J; Morgenstern D; Wilderspin AF; Neidle S; Thurston DE
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7029-32. PubMed ID: 21030257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.
    Wei CC; Ball S; Lin L; Liu A; Fuchs JR; Li PK; Li C; Lin J
    Int J Oncol; 2011 Jan; 38(1):279-85. PubMed ID: 21109950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.